Drug intelligence / Profile preview

Xiaofeng Xuanqiao

Development stage
Unknown
Lead developer
Suzhou Zhongyao Pharmaceutical Group
Modality
Small Molecules
Administration
Oral
01

Overview

Xiaofeng Xuanqiao is a Traditional Chinese Medicine (TCM) granule formulation developed by Suzhou Zhongyao Pharmaceutical Group for the treatment of perennial allergic rhinitis. Based on the TCM principles of dispelling wind and opening the nasal orifices, the formula is designed to alleviate chronic symptoms such as nasal congestion, rhinorrhea, and sneezing. The pharmacological action of Xiaofeng Xuanqiao involves the modulation of the allergic immune response, specifically by inhibiting the production of allergen-specific IgE and regulating the balance of Th1 and Th2 cytokines. Clinical development in China has progressed to Phase 3 trials, positioning it as a potential standardized herbal therapy for patients with persistent allergic rhinitis who seek alternatives to conventional antihistamines or corticosteroids.

Brand names
Xiaofeng Xuanqiao Granules
Other names
Xiaofeng Xuanqiao Keli消风宣窍颗粒
02

Targets

IL-4 (Interleukin 4)IL-5 (Interleukin 5)IL-13 (Interleukin-13)IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Xiaofeng Xuanqiao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaofeng Xuanqiao.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call